The approval clears the way for a US study at leading clinical centers to evaluate the safety and effectiveness of VDYNE’s system in patients
The study is a global, randomized, double-blind, placebo-controlled trial testing GLM101 for phosphomannomutase 2 congenital disorder of glycosylation
The FDA clearance of Zeto New Wave marks the company’s third cleared device, alongside Zeto WR19 and Zeto ONE
The initiative is aimed at strengthening the district-level screening and chronic disease management infrastructure
The new single-pill therapy combines cilnidipine, telmisartan and metoprolol, bringing together three established antihypertensive agents with complementary mechanisms
The enhanced allocation will be directed toward expanding healthcare infrastructure, increasing patient capacity, and widening acces
For the biopharma industry, the study strengthens the case for balancing immune-cell engagement with tolerability in antibody discovery platforms
Landmark procedure restores 32-year-old CKD patient’s health, highlighting how public insurance is widening access to advanced renal care
36 districts to get advanced ALS, BLS and neonatal ambulances under MEMS 108
Surgeon Yuvaraja operates on a 55-year-old patient at Medical City Hospital Muscat
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
